Motor progression trajectories and risk of mild cognitive impairment in Parkinson's disease: A latent class trajectory model from PPMI cohort
CNS Neuroscience & Therapeutics · 2024-08 · 30 (8)
DOI: 10.1111/cns.14918 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 12.08.2024. Verfasst von Xi Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shantou University Medical College, Shantou, Guangdong Province, China. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Parkinson Disease, Disease Progression. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Guangzhou, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Aims
Rare studies have investigated the association between heterogeneity of motor progression and risk of early cognitive impairment in Parkinson's disease (PD). In this study, we aim to identify distinct trajectories of motor progression longitudinally and investigate their impact on predicting mild cognitive impairment (MCI).
Methods
A 5‐year cohort including 415 PD patients at baseline was collected from the Parkinson's Progression Markers Initiative. The severity of motor symptoms was evaluated using the Movement Disorder Society Unified Parkinson's Disease Rating Scale part III. The latent class trajectory model and nonlinear mixed‐effects model were used to analyze and delineate the longitudinal changes in motor symptoms. Propensity score matching (PSM) was used to minimize the impact of potential confounders. Cox proportional hazard models were applied to calculate hazard ratios for MCI, and a Kaplan–Meier curve was generated using the occurrence of MCI during the follow‐up as the time‐to‐event.
Results
Two latent trajectories were identified: a mild and remitting motor symptoms class (Class 1, 33.01%) and a severe and progressive motor symptom class (Class 2, 66.99%). Patients in Class 2 initially exhibited severe motor symptoms that worsened progressively despite receiving anti‐PD medications. In comparison, patients in Class 1 exhibited milder symptoms that improved following drug therapy and a slower progression. During a 5‐year follow‐up, patients in Class 2 showed a higher risk of developing MCI compared to those in Class 1 before PSM (Log‐Rank 28.58, p < 0.001) and after PSM (Log‐Rank 8.20, p = 0.004).
Conclusions
PD patients with severe and progressive motor symptoms are more likely to develop MCI than those with mild and stable motor symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shantou University Medical College, Shantou, Guangdong Province, China.
- Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong Province, China.
- School of Medicine, South China University of Technology, Guangzhou, China.
- Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
- Guangzhou Key Laboratory of Diagnosis and Treatment for Neurodegenerative Diseases, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China.
ORCID-Profile: Xi Chen, Mengfei Cai, Yuhu Zhang
Förderung
- Key Research and Development Program of Guangzhou
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Chen, X., He, C., Ma, J., Yang, R., Qi, Q., Gao, Z., Du, T., Zhang, P., Li, Y., Cai, M., & Zhang, Y. (2024). Motor progression trajectories and risk of mild cognitive impairment in Parkinson's disease: A latent class trajectory model from PPMI cohort. CNS Neuroscience & Therapeutics, 30(8). https://doi.org/10.1111/cns.14918
Vancouver
Chen X, He C, Ma J, Yang R, Qi Q, Gao Z, et al. Motor progression trajectories and risk of mild cognitive impairment in Parkinson's disease: A latent class trajectory model from PPMI cohort. CNS Neuroscience & Therapeutics. 2024;30(8). doi:10.1111/cns.14918
BibTeX
@article{Chen2024,
author = {Chen, Xi and He, Chentao and Ma, Jianrui and Yang, Rui and Qi, Qi and Gao, Ziqi and Du, Tingyue and Zhang, Piao and Li, Yan and Cai, Mengfei and Zhang, Yuhu},
title = {Motor progression trajectories and risk of mild cognitive impairment in Parkinson's disease: A latent class trajectory model from PPMI cohort},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
volume = {30},
number = {8},
doi = {10.1111/cns.14918}
}
EUVIMED